These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3355585)

  • 1. A novel biologically active selenooorganic compound--VII. Biotransformation of ebselen in perfused rat liver.
    Müller A; Gabriel H; Sies H; Terlinden R; Fischer H; Römer A
    Biochem Pharmacol; 1988 Mar; 37(6):1103-9. PubMed ID: 3355585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel biologically active selenoorganic compound. VIII. Biotransformation of ebselen.
    Fischer H; Terlinden R; Löhr JP; Römer A
    Xenobiotica; 1988 Dec; 18(12):1347-59. PubMed ID: 3271007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of selenium excretion in bile by sulfobromophthalein: elucidation of the mechanism.
    Gregus Z; Perjési P; Gyurasics A
    Biochem Pharmacol; 1998 Nov; 56(10):1391-402. PubMed ID: 9825739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oxidation of ebselen metabolites to thiol oxidants catalyzed by liver microsomes and perfused rat liver.
    Akerboom TP; Sies H; Ziegler DM
    Arch Biochem Biophys; 1995 Jan; 316(1):220-6. PubMed ID: 7840620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebselen, a selenoorganic compound as glutathione peroxidase mimic.
    Sies H
    Free Radic Biol Med; 1993 Mar; 14(3):313-23. PubMed ID: 8458589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine and glutathione-dependent protective effect of PZ51 (Ebselen) against diquat-induced cytotoxicity in isolated hepatocytes.
    Cotgreave IA; Sandy MS; Berggren M; Moldéus PW; Smith MT
    Biochem Pharmacol; 1987 Sep; 36(18):2899-904. PubMed ID: 3632716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glutathione and methylation in the biliary excretion of selenium. The paradoxical effect of sulfobromophthalein.
    Gyurasics A; Perjési P; Gregus Z
    Biochem Pharmacol; 1998 Nov; 56(10):1381-9. PubMed ID: 9825738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of ebselen in plasma and its transfer to binding sites in the hepatocyte.
    Wagner G; Schuch G; Akerboom TP; Sies H
    Biochem Pharmacol; 1994 Sep; 48(6):1137-44. PubMed ID: 7945407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen).
    Müller A; Cadenas E; Graf P; Sies H
    Biochem Pharmacol; 1984 Oct; 33(20):3235-9. PubMed ID: 6487370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic transformation of methylseleninic acid through key selenium intermediate selenide.
    Suzuki KT; Kurasaki K; Ogawa S; Suzuki N
    Toxicol Appl Pharmacol; 2006 Sep; 215(2):189-97. PubMed ID: 16600319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of cysteinyl leukotrienes in non-recirculating rat liver perfusion. Hepatocyte heterogeneity in uptake and biliary excretion.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1989 Apr; 181(1):115-24. PubMed ID: 2565811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the anticancer drug flavopiridol, a new inhibitor of cyclin dependent kinases, in rat liver.
    Jäger W; Zembsch B; Wolschann P; Pittenauer E; Senderowicz AM; Sausville EA; Sedlacek HH; Graf J; Thalhammer T
    Life Sci; 1998; 62(20):1861-73. PubMed ID: 9600328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early research and development of ebselen.
    Parnham MJ; Sies H
    Biochem Pharmacol; 2013 Nov; 86(9):1248-53. PubMed ID: 24012716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and biliary excretion of the novel anticancer agent 10-hydroxycamptothecin in the isolated perfused rat liver.
    Platzer P; Thalhammer T; Reznicek G; Hamilton G; Zhang R; Jäger W
    Int J Oncol; 2001 Dec; 19(6):1287-93. PubMed ID: 11713602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the relative contributions of the diselenide and selenol forms of ebselen in the mechanism of its glutathione peroxidase-like activity.
    Morgenstern R; Cotgreave IA; Engman L
    Chem Biol Interact; 1992 Sep; 84(1):77-84. PubMed ID: 1394617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of glutathione peroxidase (GPx)-like activity and antioxidant properties of some Ebselen analogues.
    Mouithys-Mickalad Mareque A; Faez JM; Chistiaens L; Kohnen S; Deby C; Hoebeke M; Lamy M; Deby-Dupont G
    Redox Rep; 2004; 9(2):81-7. PubMed ID: 15231062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bile salts on rates of formation, accumulation, and export of mutagenic metabolites from benzo(a)pyrene produced by the perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1985 Apr; 45(4):1621-7. PubMed ID: 3978630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of albumin-bound ebselen with rat liver glutathione S-transferase and microsomal proteins.
    Nikawa T; Schuch G; Wagner G; Sies H
    Biochem Mol Biol Int; 1994 Feb; 32(2):291-8. PubMed ID: 8019434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of UCN-01 in isolated perfused rat liver: role of Mrp2 in the biliary excretion of glucuronides.
    Hagenauer B; Maier-Salamon A; Thalhammer T; Zöllner P; Senderowicz A; Jäger W
    Oncol Rep; 2004 May; 11(5):1069-75. PubMed ID: 15069549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver.
    Platzer P; Thalhammer T; Hamilton G; Ulsperger E; Rosenberg E; Wissiack R; Jäger W
    Cancer Chemother Pharmacol; 2000; 45(1):50-4. PubMed ID: 10647501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.